GWM
PAHC icon

Gilpin Wealth Management’s Phibro Animal Health PAHC Stock Holding History

Gilpin Wealth Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189 Buy
6
+3
+100% +$127 ﹤0.01% 935
2026
Q1 		$166 Buy
+3
New +$143 ﹤0.01% 893

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Gilpin Wealth Management's PAHC Position: Q2 2026 in Review

Gilpin Wealth Management increased its Phibro Animal Health (PAHC) stake by 100% in Q2 2026, buying an estimated $127 and bringing the position to 6 shares worth $189. The position accounts for ﹤0.01% of the portfolio, ranked #935.

Gilpin Wealth Management first reported a position in PAHC in Q1 2026 and has held it in 2 quarters since. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Gilpin Wealth Management held 6 shares of Phibro Animal Health worth $189 as of Q2 2026.
  • Gilpin Wealth Management bought 3 Phibro Animal Health shares in Q2 2026, an estimated $127.
  • Phibro Animal Health made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #935 holding.
  • Gilpin Wealth Management first reported a position in Phibro Animal Health in Q1 2026 and has held it in 2 quarters since.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.